Cedric Francois - Feb 27, 2023 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
Chief Executive Officer, Director
Signature
/s/ David Watson, attorney-in-fact for Cedric Francois
Stock symbol
APLS
Transactions as of
Feb 27, 2023
Transactions value $
$376,000
Form type
4
Date filed
3/1/2023, 03:10 PM
Previous filing
Feb 22, 2023
Next filing
Mar 23, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Options Exercise $376K +100K +9.57% $3.76* 1.14M Feb 27, 2023 Direct
holding APLS Common Stock 300K Feb 27, 2023 Indirect Owner (The Francois Grossi Trust) F1
holding APLS Common Stock 234K Feb 27, 2023 Indirect Owner (The Francois-DuBois Educational Trust) F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APLS Stock Option (Right to Buy) Options Exercise $0 -100K -38.63% $0.00 159K Feb 27, 2023 Common Stock 100K $3.76 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The securities are held by The Francois Grossi Trust, for which Juliana Grossi, the spouse of the reporting person, serves as trustee. The reporting person disclaims beneficial ownership over the shares held by the Francois Grossi Trust except to the extent of his pecuniary interest therein.
F2 The securities are held by The Francois-DuBois Educational Trust, for which the Fiduciary Trust Company of New England serves as trustee. The reporting person disclaims beneficial ownership over the shares held by The Francois-DuBois Educational Trust except to the extent of his pecuniary interest therein.
F3 This option was granted on February 8, 2016 and fully vested.